ID   ST32C_HUMAN             Reviewed;         486 AA.
AC   Q86UX6; Q5T0Q5; Q86UE1;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   15-MAR-2017, entry version 127.
DE   RecName: Full=Serine/threonine-protein kinase 32C;
DE            EC=2.7.11.1;
DE   AltName: Full=PKE;
DE   AltName: Full=Yet another novel kinase 3;
GN   Name=STK32C {ECO:0000312|EMBL:AAH45760.1}; Synonyms=YANK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAM21719.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ma A.-H., Nelson D.A., Xia L., Ravi L., Chen H.-C., Robinson D.R.,
RA   Kung H.-J.;
RT   "PKE, a new human AGC group kinase, phosphorylates SET, a PP2A
RT   inhibitor.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000312|EMBL:CAI12181.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH45760.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ALA-334.
RC   TISSUE=Testis {ECO:0000312|EMBL:AAH45760.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   NOMENCLATURE.
RX   PubMed=12471243; DOI=10.1126/science.1075762;
RA   Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S.;
RT   "The protein kinase complement of the human genome.";
RL   Science 298:1912-1934(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND SER-18, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-376.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-454 AND LYS-467.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000250|UniProtKB:Q60592}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q60592};
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86UX6-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:15489334};
CC         IsoId=Q86UX6-2; Sequence=VSP_051998;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY098866; AAM21719.1; -; mRNA.
DR   EMBL; AL512622; CAI12181.1; -; Genomic_DNA.
DR   EMBL; AL590105; CAI12181.1; JOINED; Genomic_DNA.
DR   EMBL; AL512622; CAI12187.1; -; Genomic_DNA.
DR   EMBL; AL590105; CAI13011.1; -; Genomic_DNA.
DR   EMBL; AL512622; CAI13011.1; JOINED; Genomic_DNA.
DR   EMBL; BC045760; AAH45760.1; -; mRNA.
DR   CCDS; CCDS7666.1; -. [Q86UX6-1]
DR   CCDS; CCDS81525.1; -. [Q86UX6-2]
DR   RefSeq; NP_001305808.1; NM_001318879.1. [Q86UX6-2]
DR   RefSeq; NP_775846.2; NM_173575.3. [Q86UX6-1]
DR   RefSeq; XP_011537995.1; XM_011539693.2. [Q86UX6-2]
DR   RefSeq; XP_011537996.1; XM_011539694.1. [Q86UX6-2]
DR   RefSeq; XP_011537997.1; XM_011539695.1. [Q86UX6-2]
DR   RefSeq; XP_011537998.1; XM_011539696.1. [Q86UX6-2]
DR   UniGene; Hs.469002; -.
DR   UniGene; Hs.665362; -.
DR   UniGene; Hs.671431; -.
DR   UniGene; Hs.729440; -.
DR   ProteinModelPortal; Q86UX6; -.
DR   SMR; Q86UX6; -.
DR   BioGrid; 129429; 8.
DR   IntAct; Q86UX6; 2.
DR   STRING; 9606.ENSP00000298630; -.
DR   BindingDB; Q86UX6; -.
DR   ChEMBL; CHEMBL5405; -.
DR   GuidetoPHARMACOLOGY; 1539; -.
DR   iPTMnet; Q86UX6; -.
DR   PhosphoSitePlus; Q86UX6; -.
DR   BioMuta; STK32C; -.
DR   DMDM; 74762451; -.
DR   EPD; Q86UX6; -.
DR   MaxQB; Q86UX6; -.
DR   PaxDb; Q86UX6; -.
DR   PeptideAtlas; Q86UX6; -.
DR   PRIDE; Q86UX6; -.
DR   Ensembl; ENST00000298630; ENSP00000298630; ENSG00000165752. [Q86UX6-1]
DR   Ensembl; ENST00000368622; ENSP00000357611; ENSG00000165752. [Q86UX6-2]
DR   GeneID; 282974; -.
DR   KEGG; hsa:282974; -.
DR   UCSC; uc001lld.2; human. [Q86UX6-1]
DR   CTD; 282974; -.
DR   DisGeNET; 282974; -.
DR   GeneCards; STK32C; -.
DR   HGNC; HGNC:21332; STK32C.
DR   HPA; HPA017894; -.
DR   neXtProt; NX_Q86UX6; -.
DR   OpenTargets; ENSG00000165752; -.
DR   PharmGKB; PA134888050; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00860000133734; -.
DR   HOGENOM; HOG000021314; -.
DR   HOVERGEN; HBG106458; -.
DR   InParanoid; Q86UX6; -.
DR   KO; K08793; -.
DR   OMA; CEMTLAL; -.
DR   OrthoDB; EOG091G0XV4; -.
DR   PhylomeDB; Q86UX6; -.
DR   TreeFam; TF313395; -.
DR   SignaLink; Q86UX6; -.
DR   GenomeRNAi; 282974; -.
DR   PRO; PR:Q86UX6; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000165752; -.
DR   CleanEx; HS_STK32C; -.
DR   ExpressionAtlas; Q86UX6; baseline and differential.
DR   Genevisible; Q86UX6; HS.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    486       Serine/threonine-protein kinase 32C.
FT                                /FTId=PRO_0000232415.
FT   DOMAIN       93    353       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      99    107       ATP. {ECO:0000250|UniProtKB:Q60592,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   ACT_SITE    216    216       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:Q60592,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159,
FT                                ECO:0000255|PROSITE-ProRule:PRU10027}.
FT   BINDING     122    122       ATP. {ECO:0000250|UniProtKB:Q60592,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8QZV4}.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      18     18       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    117       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_051998.
FT   VARIANT     334    334       T -> A (in dbSNP:rs17854384).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_025900.
FT   VARIANT     376    376       R -> H (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs764558009).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035637.
FT   VARIANT     454    454       A -> T (in dbSNP:rs56109103).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041170.
FT   VARIANT     467    467       E -> K (in dbSNP:rs55812591).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041171.
SQ   SEQUENCE   486 AA;  54994 MW;  38FEFBB3863B21F3 CRC64;
     MRSGAERRGS SAAASPGSPP PGRARPAGSD APSALPPPAA GQPRARDSGD VRSQPRPLFQ
     WSKWKKRMGS SMSAATARRP VFDDKEDVNF DHFQILRAIG KGSFGKVCIV QKRDTEKMYA
     MKYMNKQQCI ERDEVRNVFR ELEILQEIEH VFLVNLWYSF QDEEDMFMVV DLLLGGDLRY
     HLQQNVQFSE DTVRLYICEM ALALDYLRGQ HIIHRDVKPD NILLDERGHA HLTDFNIATI
     IKDGERATAL AGTKPYMAPE IFHSFVNGGT GYSFEVDWWS VGVMAYELLR GWRPYDIHSS
     NAVESLVQLF STVSVQYVPT WSKEMVALLR KLLTVNPEHR LSSLQDVQAA PALAGVLWDH
     LSEKRVEPGF VPNKGRLHCD PTFELEEMIL ESRPLHKKKK RLAKNKSRDN SRDSSQSEND
     YLQDCLDAIQ QDFVIFNREK LKRSQDLPRE PLPAPESRDA AEPVEDEAER SALPMCGPIC
     PSAGSG
//
